BlossomHill Therapeutics, Inc. (BLSM) stock
Close on Nov 17, 2026Market cap $38.56MP/E –Yield –
Earnings
BlossomHill Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of BlossomHill Therapeutics's earnings releases, newest first
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
BlossomHill Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When BlossomHill Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases BlossomHill Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
See a number that looks wrong?